6,561 Shares in Corteva, Inc. $CTVA Acquired by R Squared Ltd

R Squared Ltd acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 6,561 shares of the company’s stock, valued at approximately $444,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Empirical Finance LLC grew its holdings in shares of Corteva by 0.6% during the 2nd quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after acquiring an additional 153 shares in the last quarter. Fox Run Management L.L.C. grew its stake in Corteva by 5.1% in the third quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock valued at $227,000 after purchasing an additional 164 shares in the last quarter. United Community Bank increased its position in Corteva by 10.5% in the 3rd quarter. United Community Bank now owns 1,849 shares of the company’s stock worth $125,000 after purchasing an additional 176 shares during the last quarter. Binnacle Investments Inc raised its stake in shares of Corteva by 54.7% during the 2nd quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock worth $38,000 after purchasing an additional 181 shares in the last quarter. Finally, Cresset Asset Management LLC raised its stake in shares of Corteva by 2.6% during the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of CTVA opened at $80.01 on Friday. The company has a market capitalization of $53.81 billion, a PE ratio of 50.64, a price-to-earnings-growth ratio of 2.69 and a beta of 0.75. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a one year low of $53.40 and a one year high of $80.23. The company’s fifty day moving average price is $71.91 and its 200 day moving average price is $68.83.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm’s revenue was down 1.7% compared to the same quarter last year. During the same period last year, the business posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s payout ratio is currently 45.57%.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. The Goldman Sachs Group restated a “buy” rating and set a $88.00 price target on shares of Corteva in a report on Thursday, February 5th. JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and upped their price objective for the stock from $75.00 to $77.00 in a report on Thursday, February 5th. Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Finally, Wolfe Research boosted their price target on Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, Corteva presently has an average rating of “Moderate Buy” and an average price target of $82.30.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.14% of the company’s stock.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.